EFFECT ·Filed Apr 1, 2026
ED

EDAP

EDAP TMS SA
NEUTRAL
Impact 4/10
Horizonmonths Processed6mo ago SEC9999999995-26-001026
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any takedown of the shelf offering, which could lead to near-term dilution. The presence of EIB-held warrants may influence future capital structure decisions and share price volatility if exercised.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
EDAP ▲ +44.48% at T+60d
NEUTRAL call ✓ call won +44.48% · α vs SPY +31.10% · entry $3.53 → $5.10
Entry anchored
Mar 31, 03:47 PM ET
via exchange tick
T+1d
-3.97%
call -3.97% · α -4.05%
$3.39
settled 6mo ago
T+5d
-4.82%
call -4.82% · α -8.58%
$3.36
settled 6mo ago
T+20d
-6.23%
call -6.23% · α -15.95%
$3.31
settled 5mo ago
T+60d
+44.48%
call +44.48% · α +31.10%
$5.10
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

EDAP TMS SA's shelf registration (S-3) has become effective, allowing the company to issue up to $125 million in securities, including ordinary shares, preferred shares, and warrants. The registration also permits resale of up to 4,574,421 ordinary shares issuable under warrants held by the European Investment Bank. This provides capital-raising flexibility but introduces potential future dilution.

Key Facts

  • S-3 shelf registration became effective on 2026-03-31
  • Registration allows issuance of up to $125 million in securities
  • Covers resale of up to 4,574,421 ordinary shares tied to European Investment Bank warrants
  • Company will not receive proceeds from resale, but may benefit if warrants are exercised

Financial Impact

$125 million in potential future issuances; warrant-related share resale exposure of 4.57 million shares

dilutionequitycashFlow

Risk Factors

  • Potential share dilution if company issues new securities under the shelf
  • Downward pressure on stock price if EIB or other holders sell registered shares

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001026
Document: 9999999995-26-001026-index.html9999999995-26-001026
Document: 9999999995-26-001026.txt9999999995-26-001026
12 reports for EDAP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EDAP — sortable, filterable
TypeNow
Aug 17, 2026
6w ago
Insider Cluster
MIXED ★ 5/10
—awaiting T+20——
May 29, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$4.32 $5.10▲ +18.06%▲ +19.85%—
May 14, 2026
20w ago
DEFA14A
BEARISH ★ 6/10
$4.13 $4.77▼ −15.50%▼ −16.35%—
May 14, 2026
20w ago
DEFA14A
NEUTRAL ★ 3/10
$4.13 $4.77▲ +15.50%▲ +16.35%—
May 14, 2026
20w ago
Press Release
NEUTRAL ★ 3/10
$4.13 $4.77▲ +15.50%▲ +16.35%—
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$4.16 $4.69▲ +12.74%▲ +9.60%—
Apr 16, 2026
24w ago
Press Release
NEUTRAL ★ 3/10
$3.59 $4.16▲ +15.88%▲ +10.06%—
Apr 1, 2026
26w ago
EFFECT
NEUTRAL ★ 4/10
$3.53 $3.31▼ −6.23%▼ −15.95%—
Mar 27, 2026
27w ago
S-3/A
NEUTRAL ★ 4/10
$3.73 $3.22▼ −13.67%▼ −26.41%—
Mar 25, 2026
27w ago
S-3
NEUTRAL ★ 5/10
$3.77 $3.22▼ −14.59%▼ −25.25%—
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (37h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access